» Articles » PMID: 18368417

Management of Peripheral Facial Nerve Palsy

Overview
Date 2008 Mar 28
PMID 18368417
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

Peripheral facial nerve palsy (FNP) may (secondary FNP) or may not have a detectable cause (Bell's palsy). Three quarters of peripheral FNP are primary and one quarter secondary. The most prevalent causes of secondary FNP are systemic viral infections, trauma, surgery, diabetes, local infections, tumor, immunological disorders, or drugs. The diagnosis of FNP relies upon the presence of typical symptoms and signs, blood chemical investigations, cerebro-spinal-fluid-investigations, X-ray of the scull and mastoid, cerebral MRI, or nerve conduction studies. Bell's palsy may be diagnosed after exclusion of all secondary causes, but causes of secondary FNP and Bell's palsy may coexist. Treatment of secondary FNP is based on the therapy of the underlying disorder. Treatment of Bell's palsy is controversial due to the lack of large, randomized, controlled, prospective studies. There are indications that steroids or antiviral agents are beneficial but also studies, which show no beneficial effect. Additional measures include eye protection, physiotherapy, acupuncture, botulinum toxin, or possibly surgery. Prognosis of Bell's palsy is fair with complete recovery in about 80% of the cases, 15% experience some kind of permanent nerve damage and 5% remain with severe sequelae.

Citing Articles

Expression Patterns of SMAD1-8 in the Peripheral Facial Nerve Following Compressive Nerve Injury or Axotomy.

Lee J, Yon D, Kim S, Yeo S Int J Mol Sci. 2025; 26(5).

PMID: 40076910 PMC: 11900376. DOI: 10.3390/ijms26052291.


Free-flap surgery with double innervation for smiling restoration in long standing facial paralysis: a literature review.

De Berardinis R, Santoro V, Tagliabue M, Allevi F, Chu F, Riccio S Eur Arch Otorhinolaryngol. 2025; .

PMID: 40053090 DOI: 10.1007/s00405-025-09287-y.


Bell's Palsy: Description, Diagnosis, and Current Management.

Gardner S, Garber L, Grossi J Cureus. 2025; 17(1):e77656.

PMID: 39974265 PMC: 11835628. DOI: 10.7759/cureus.77656.


Systematic evaluation and meta-analysis of the efficacy of Jingjin acupuncture therapy in the treatment of peripheral facial palsy.

Kang X, Huang Y, Lv X, Liu X, Chen S, Ma L Front Neurol. 2025; 15:1459738.

PMID: 39748861 PMC: 11693931. DOI: 10.3389/fneur.2024.1459738.


Chronic Facial Paralysis Treated With Non-absorbable APTOS Barbed Threads: A Case Report With Anatomic Considerations.

Mazreku M, Feltsan T, Falougy H, Bevizova K Cureus. 2024; 16(6):e62539.

PMID: 39022483 PMC: 11254316. DOI: 10.7759/cureus.62539.


References
1.
Kinishi M, AMATSU M, Hosomi H . Conservative treatment of Bell's palsy with steroids and dextran-pentoxiphylline combined therapy. Eur Arch Otorhinolaryngol. 1991; 248(3):147-9. DOI: 10.1007/BF00178925. View

2.
Rowlands S, Hooper R, Hughes R, Burney P . The epidemiology and treatment of Bell's palsy in the UK. Eur J Neurol. 2002; 9(1):63-7. DOI: 10.1046/j.1468-1331.2002.00343.x. View

3.
Lejeune D, Bernat I, Vitte E, Lamas G, Willer J, Soudant J . [Treatment of Bell's palsy with acyclovir and methylprednisolone]. Ann Otolaryngol Chir Cervicofac. 2002; 119(4):209-15. View

4.
Wolf S . [Idiopathic facial paralysis]. HNO. 1998; 46(9):786-98. DOI: 10.1007/s001060050314. View

5.
Urban P, Forst T, Lenfers M, Koehler J, Connemann B, Beyer J . Incidence of subclinical trigeminal and facial nerve involvement in diabetes mellitus. Electromyogr Clin Neurophysiol. 1999; 39(5):267-72. View